Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 79

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 79
---
 Stock Warrants, or 485 shares of our common stock upon cash exercise with an exercise price 
 of $16.00 per share;                                                                                                                |

| ● | 5,060 shares of common stock issuable upon the exercise of                    
 the Class D Common Stock Warrants, with an exercise price of $3.76 per share; |

| ● | 64,506 shares of common stock issuable upon the exercise                          
 of the Class E Common Stock Warrants, with an exercise price of $16.00 per share; |

| ● | 125,000 shares of our common stock issuable upon the alternative cashless exercise of the Class F Common Stock Warrants, or 62,500 shares of our common stock upon cash exercise with an exercise price of $16.00 per share; |

| ● | 1,621,463 shares of common stock issuable upon the exercise of the Class G Common Stock Warrants, with an exercise price of $3.76 per share; and |

| ● | shares of common stock issuable upon the exercise                      
 of the Class H Common Stock Warrants issued pursuant to this offering. |

48 DILUTION If you invest in our securities in this offering, your interest will be diluted to the extent of the difference between the public offering price per share of common stock and accompanying Common Stock Warrants and the pro forma as adjusted net tangible book value per share of common stock immediately after this offering. Our net tangible book value is the amount of our total tangible assets less our total liabilities. We had a net tangible book value as of March 31, 2025 of $2,880,752, or $2.99 per share of common stock. Pro forma as adjusted net tangible book value is our pro forma net tangible book value, plus the effect of the sale of our securities in this offering at the assumed public offering price of $2.565 per share of common stock and accompanying Common Stock Warrants and after deducting the Placement Agent fees and commissions and other estimated offering expenses payable by us. Our pro forma as adjusted net tangible book value as of March 31, 2025 would have been approximately $7,216,159, or $2.48 per share. This amount represents an immediate decrease in pro forma as adjusted net tangible book value of approximately $(0.51) per share to our existing stockholders, and an immediate dilution of $0.085 per share to new investors participating in this offering. Dilution per share to new investors is